Form 4: Maravai LifeSciences Director Gregory Lucier Gifts Over 89,000 Shares to Family Partnership

Maravai LifeSciences Holdings, Inc. Director Gregory T. Lucier reported gifting 89,139 shares of Class A Common Stock to a family partnership, altering his direct and indirect beneficial ownership.

Summary

• Gregory T. Lucier, a Director of Maravai LifeSciences Holdings, Inc. (MRVI), reported a gift transaction of Class A Common Stock.
• On July 10, 2025, Mr. Lucier disposed of 89,139 shares from his direct ownership.
• Concurrently, 89,139 shares were acquired indirectly by a family partnership, with a transaction price of $0 per share, indicating a gift.
• Following this transaction, Mr. Lucier directly beneficially owns 55,123 shares of Class A Common Stock.
• The family partnership, which includes a trust for Mr. Lucier's benefit, indirectly beneficially owns 109,784 shares.
• Mr. Lucier's spouse serves as the general partner of the family partnership and may have voting and dispositive power over the gifted shares.
• Mr. Lucier disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Sentiment

Score: 5

Explanation: A gift transaction is generally neutral for the company's stock price, as it represents an internal transfer for estate planning rather than a sale or purchase indicating a change in investment thesis.

Positives

• The transaction is a gift, not a sale, indicating that the shares remain within the insider's broader control for estate planning purposes rather than being divested from the company.
• The reporting person continues to hold a significant number of shares, both directly and indirectly, aligning his interests with shareholders.

Negatives

• No direct negatives for the company are apparent from this gift transaction.

Risks

• The reporting person disclaims beneficial ownership of the gifted shares except to the extent of his pecuniary interest, which could imply a slight reduction in direct control over those specific shares, though they remain within a family entity.

Future Outlook

Not applicable. This document reports a past transaction and does not provide forward-looking statements or guidance.

Management Comments

• "Represents shares gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person."
• "The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such shares."
• "The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 of the Exchange Act or for any other purpose."

Industry Context

This Form 4 filing is specific to an individual insider transaction and does not provide broader industry context or trends.

Related Party Transactions

• The gift of shares to a family partnership, where the reporting person's spouse is the general partner and a trust for the reporting person's benefit is a partner, constitutes a related party transaction.

Stakeholder Impact

• Shareholders: Minimal direct impact as the shares remain within the insider's broader family control and are not entering the open market.
• Employees, Customers, Suppliers, Creditors: No direct impact from this internal share transfer.

Key Dates

Keywords

Maravai LifeSciences, MRVI, Gregory T. Lucier, Form 4, insider transaction, stock gift, director, beneficial ownership, family partnership, Class A Common Stock